Blog
25 May 2026
Upadacitinib Shows Stable Lab Safety in Atopic Dermatitis After 3 Years
Upadacitinib shows stable lab safety over 3 years in moderate to severe atopic dermatitis, offering important insights for long-term treatment...
Read more
How Dermatologists Tailor Sun Protection Advice for Every Skin Concern
Discover how dermatologists customize sun protection tips for different skin concerns, including mineral vs. chemical sunscreens and sensitive skin needs.
22 05 2026
Read more
Extended-Release Oral Minoxidil Shows Promise for Treating Hair Loss
Extended-release oral minoxidil shows promising results in treating androgenetic alopecia, offering a potential new FDA-approved option for hair loss.
23 05 2026
Read more
Bimekizumab Shows Superior Results Over Risankizumab in Psoriatic Arthritis Trial
Bimekizumab outperforms risankizumab in a phase 3 trial for psoriatic arthritis, showing superior joint improvement at 16 weeks. Learn more...
24 05 2026
Read more
How Phages Could Transform Acne and Body Odor Treatments Naturally
Discover how phages, natural bacteria-fighting viruses, could revolutionize acne and body odor treatments without antibiotics or harming your skin’s microbiome.
21 05 2026
Read more
Higher Starting Dose in Excimer Laser Speeds Vitiligo Repigmentation
Discover how a higher starting dose in excimer laser therapy speeds vitiligo repigmentation, offering faster, effective results without increased side...
20 05 2026
Read more
When Ideal Skin Treatments Aren’t an Option: Real Patient Challenges
Discover real patient struggles when ideal skin treatments like acne, psoriasis, and eczema therapies aren’t accessible due to cost, insurance,...
20 05 2026
Read more
Codex Labs Wins US Patents for Steroid-Free Eczema Treatment Tech
Codex Labs secures US patents for steroid-free BiaComplex eczema treatment, offering safe, effective relief for atopic dermatitis without skin-thinning risks.
20 05 2026
Read more
How Microbial Balance Is Revolutionizing Skin Care: Insights from Epicutis CEO Maxwell Stock
Discover how microbial balance is transforming skin care with insights from Epicutis CEO Maxwell Stock on microbiome-focused dermatology breakthroughs.
19 05 2026
Read more